JP2003088383A - Methods for collecting biomolecules from living cells - Google Patents
Methods for collecting biomolecules from living cellsInfo
- Publication number
- JP2003088383A JP2003088383A JP2001284298A JP2001284298A JP2003088383A JP 2003088383 A JP2003088383 A JP 2003088383A JP 2001284298 A JP2001284298 A JP 2001284298A JP 2001284298 A JP2001284298 A JP 2001284298A JP 2003088383 A JP2003088383 A JP 2003088383A
- Authority
- JP
- Japan
- Prior art keywords
- collecting
- mrna
- gene
- needle
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 40
- 238000000605 extraction Methods 0.000 claims abstract 2
- 108090000623 proteins and genes Proteins 0.000 claims description 27
- 108020004999 messenger RNA Proteins 0.000 claims description 23
- 230000014509 gene expression Effects 0.000 claims description 14
- 239000012634 fragment Substances 0.000 claims description 13
- 239000002299 complementary DNA Substances 0.000 claims description 11
- 238000003752 polymerase chain reaction Methods 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 238000000018 DNA microarray Methods 0.000 claims description 3
- 108091034117 Oligonucleotide Proteins 0.000 claims description 3
- 230000002194 synthesizing effect Effects 0.000 claims description 3
- 210000004027 cell Anatomy 0.000 description 62
- 239000004593 Epoxy Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000003757 reverse transcription PCR Methods 0.000 description 4
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 3
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 3
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 3
- 108010085238 Actins Proteins 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000003431 cross linking reagent Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000007857 nested PCR Methods 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- ASNTZYQMIUCEBV-UHFFFAOYSA-N 2,5-dioxo-1-[6-[3-(pyridin-2-yldisulfanyl)propanoylamino]hexanoyloxy]pyrrolidine-3-sulfonic acid Chemical compound O=C1C(S(=O)(=O)O)CC(=O)N1OC(=O)CCCCCNC(=O)CCSSC1=CC=CC=N1 ASNTZYQMIUCEBV-UHFFFAOYSA-N 0.000 description 1
- KZDCMKVLEYCGQX-UDPGNSCCSA-N 2-(diethylamino)ethyl 4-aminobenzoate;(2s,5r,6r)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid;hydrate Chemical compound O.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1.N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 KZDCMKVLEYCGQX-UDPGNSCCSA-N 0.000 description 1
- ZPZDIFSPRVHGIF-UHFFFAOYSA-N 3-aminopropylsilicon Chemical compound NCCC[Si] ZPZDIFSPRVHGIF-UHFFFAOYSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 102100033040 Carbonic anhydrase 12 Human genes 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102100036738 Guanine nucleotide-binding protein subunit alpha-11 Human genes 0.000 description 1
- 101000867855 Homo sapiens Carbonic anhydrase 12 Proteins 0.000 description 1
- 101100283445 Homo sapiens GNA11 gene Proteins 0.000 description 1
- 108010002724 Pheromone Receptors Proteins 0.000 description 1
- 102100032491 Serine protease 1 Human genes 0.000 description 1
- 101710151387 Serine protease 1 Proteins 0.000 description 1
- 101710119665 Trypsin-1 Proteins 0.000 description 1
- 102100038344 Vomeronasal type-1 receptor 2 Human genes 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000002041 carbon nanotube Substances 0.000 description 1
- 229910021393 carbon nanotube Inorganic materials 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000002073 fluorescence micrograph Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000010230 functional analysis Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000004498 neuroglial cell Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000002427 pheromone receptor Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 210000001121 vomeronasal organ Anatomy 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
(57)【要約】
【課題】 生きた細胞からRNAなどの生体分子を採取す
る手段を提供する。
【解決手段】 少なくとも以下の(1)及び(2)の工
程を含むことを特徴とする生体分子の採取方法。
(1)採取しようとする生体分子と結合し得る針を、微
細な位置制御が可能な装置を用いて、生細胞に刺し込む
工程
(2)前記針を、前記装置を用いて、生細胞から引き抜
く工程(57) [Summary] [PROBLEMS] To provide means for collecting biomolecules such as RNA from living cells. A method for collecting biomolecules, comprising at least the following steps (1) and (2). (1) a step of piercing a needle capable of binding to a biomolecule to be collected into a living cell using a device capable of fine position control; (2) inserting the needle from a living cell using the device; Extraction process
Description
【0001】[0001]
【発明の属する技術分野】本発明は、生きている状態の
細胞から種々の生体分子を採取する方法、及びその方法
を利用した生細胞内で発現している遺伝子の同定方法に
関する。本発明の方法により、一つの細胞における遺伝
子発現等の変化を経時的に調べることが可能になる。TECHNICAL FIELD The present invention relates to a method for collecting various biomolecules from a living cell and a method for identifying a gene expressed in a living cell using the method. The method of the present invention makes it possible to examine changes in gene expression and the like in one cell over time.
【0002】[0002]
【従来の技術】最近の生物学研究の大きな流れの一つ
は、個々の生物試料の個性を調べようというものであ
る。タンパク質などの生体高分子にしても、たくさんの
分子からなる溶液中の酵素活性などといった全体の性質
を調べるだけでなく、一分子の活性を調べるというもの
で、これらの学問は一分子生化学と呼ばれている。2. Description of the Related Art One of the major trends in recent biological research is to investigate the individuality of individual biological samples. Even in the case of biopolymers such as proteins, it is not only to investigate the whole properties such as enzyme activity in a solution consisting of many molecules, but also to investigate the activity of a single molecule. being called.
【0003】細胞生物学の分野においても一つ一つの細
胞の個性を調べる研究が行われるようになってきた。例
えば、脳のある領域の神経細胞では、従来は同じ種類の
細胞の集まりとして扱われてきた。これら同じ種類の細
胞集団の中の個々細胞のレセプターなどの微妙な発現の
違いを調べることにより、より複雑な機能解析を行うこ
とができるのではないかと考えられるようになってき
た。一分子生化学に対して一細胞生物学と呼ぶことがで
きよう。In the field of cell biology, studies have been conducted to investigate the individuality of each cell. For example, a nerve cell in a certain area of the brain has conventionally been treated as a collection of cells of the same type. By investigating subtle differences in expression of receptors and the like of individual cells in these cell populations of the same type, it has been considered that more complicated functional analysis can be performed. One could call it single cell biology for single molecule biochemistry.
【0004】一つの細胞での遺伝子発現変化などを観察
するためには細胞を生きたまま、そこからわずかな量の
生体分子を取り出し解析する技術が不可欠である。今ま
では同じ状態にあると思われる複数の細胞間での比較を
行ってきたが、今後微妙な細胞間の変化などを調べる一
細胞生物学を行うには十分な方法とはいえない。[0004] In order to observe changes in gene expression in one cell, it is indispensable to take out a small amount of biomolecule from the living cell and analyze it. Until now, comparisons have been made among multiple cells that seem to be in the same state, but it cannot be said to be a sufficient method for conducting one-cell biology for investigating subtle changes between cells in the future.
【0005】最近、複数の鋤鼻神経細胞の一つ一つから
cDNAライブラリーを作り、それらを比較することによ
り、微妙な遺伝子の発現を調べて、フェロモンレセプタ
ーのクローニングなどが行われた。この方法は大変画期
的であるが、今までの方法と同じように細胞を殺してし
まうため、経時的な変化を一つの細胞で調べることがで
きない。Recently, from each of a plurality of vomeronasal nerve cells
By making a cDNA library and comparing them, subtle gene expression was investigated, and cloning of the pheromone receptor was performed. This method is very revolutionary, but it kills cells in the same way as previous methods, so it is not possible to examine changes over time with a single cell.
【0006】[0006]
【発明が解決しようとする課題】以上述べたように、従
来の生体分子の採取方法は、採取源とする細胞を殺すこ
とを前提としており、細胞を生かした状態で生体分子を
採取しようとする方法は知られていなかった。As described above, the conventional method for collecting biomolecules is based on the premise of killing cells as a collection source, and attempts to collect biomolecules in a state where the cells are kept alive. The method was unknown.
【0007】本発明は、このような技術的な背景の下に
なされたものであり、その目的は、生きた細胞からRNA
などの生体分子を採取する手段を提供し、個々の細胞に
ついて経時的な変化を連続的に記録することにある。The present invention has been made under such a technical background, and its purpose is to obtain RNA from living cells.
It is to provide a means for collecting biomolecules such as and continuously record changes over time in individual cells.
【0008】[0008]
【課題を解決するための手段】本発明者は、一つの細胞
での遺伝子発現変化などを観察するためには、生きた状
態の細胞から生体分子を取り出すことが必要であるとい
う着想を得、この着想を基に本発明を完成した。Means for Solving the Problems The present inventor has the idea that it is necessary to extract biomolecules from cells in a living state in order to observe changes in gene expression in one cell. The present invention has been completed based on this idea.
【0009】即ち、本発明は、少なくとも以下の(1)
及び(2)の工程を含むことを特徴とする生体分子の採
取方法である。
(1)採取しようとする生体分子と結合し得る針を、微
細な位置制御が可能な装置を用いて、生細胞に刺し込む
工程
(2)前記針を、前記装置を用いて、生細胞から引き抜
く工程
また、本発明は、少なくとも以下の(1)及び(2)の
工程を含むことを特徴とする生細胞内で発現している遺
伝子の同定方法である。
(1)上記方法によって生細胞からmRNAを採取する工程
(2)前記mRNAと、発現が予想される遺伝子に特異的な
配列を含むオリゴヌクレオチドとを共存させ、前者を鋳
型とし、後者をプライマーとするポリメラーゼ連鎖反応
が起きるかどうかを調べる工程
更に、本発明は、少なくとも以下の(1)〜(3)の工
程を含むことを特徴とする生細胞内で発現している遺伝
子の同定方法である。
(1)上記方法によって生細胞からmRNAを採取する工程
(2)前記mRNAからcDNAを合成する工程
(3)前記cDNAを、発現が予想される複数の遺伝子断片
が固定されているDNAチップに近づけ、前記cDNAと固定
されている遺伝子断片間に生じる力を測定する工程That is, the present invention is at least the following (1)
And a method of collecting a biomolecule, which includes the steps (2) and (2). (1) A step of inserting a needle capable of binding to a biomolecule to be collected into a living cell by using a device capable of finely controlling the position (2) A step of inserting the needle from the living cell by using the device Further, the present invention is a method for identifying a gene expressed in a living cell, which comprises at least the following steps (1) and (2). (1) Step of collecting mRNA from living cells by the above method (2) The mRNA and an oligonucleotide containing a sequence specific to a gene whose expression is expected to coexist, the former as a template, and the latter as a primer The step of investigating whether or not the polymerase chain reaction occurs is further present, and the present invention is a method for identifying a gene expressed in a living cell, which comprises at least the following steps (1) to (3): . (1) Step of collecting mRNA from living cells by the above method (2) Step of synthesizing cDNA from said mRNA (3) Bringing said cDNA close to a DNA chip on which a plurality of gene fragments whose expression is expected are fixed Measuring the force generated between the cDNA and the fixed gene fragment
【発明の実施の形態】以下、本発明を詳細に説明する。BEST MODE FOR CARRYING OUT THE INVENTION The present invention will be described in detail below.
【0010】本発明の生体分子の採取方法は、少なくと
も以下の(1)及び(2)の工程を含むことを特徴とす
るものである。The method for collecting biomolecules of the present invention is characterized by including at least the following steps (1) and (2).
【0011】工程(1)では、採取しようとする生体分
子と結合し得る針を、微細な位置制御が可能な装置を用
いて、生細胞に刺し込む。In step (1), a needle capable of binding to a biomolecule to be collected is inserted into a living cell using a device capable of finely controlling the position.
【0012】生体分子としては、mRNA、tRNA、rRNA、DN
A、タンパク質、脂質、糖などを挙げることができる。Biomolecules include mRNA, tRNA, rRNA, DN
A, protein, lipid, sugar, etc. can be mentioned.
【0013】使用する針は、生体分子と結合し得るもの
であればどのようなものでもよく、例えば、金属酸化物
のウィスカー(例えば、ZnOウィスカーなど)、カーボ
ンナノチューブなどを使用することができる。ウィスカ
ー等は、そのままの状態でも物理的吸着力によって生体
分子と結合できるが、結合性を向上させるため、生体分
子と特異的に結合し得る物質で修飾することが好まし
い。生体分子と特異的に結合し得る物質としては、例え
ば、mRNAを採取する場合であればオリゴdTを例示するこ
とができ、タンパク質、脂質、糖を採取する場合であれ
ば抗体を例示することができる。また、特定の配列を持
つ核酸を採取しようとする場合には、その核酸と相補的
な配列を持つ核酸で針を修飾してもよい。Any needle may be used as long as it can bind to biomolecules, and for example, metal oxide whiskers (for example, ZnO whiskers) and carbon nanotubes can be used. Whiskers and the like can be bound to biomolecules by a physical adsorption force in a state as they are, but it is preferable to modify them with a substance capable of specifically binding to biomolecules in order to improve the binding property. Examples of the substance capable of specifically binding to a biomolecule include oligo dT in the case of collecting mRNA, and an antibody in the case of collecting proteins, lipids and sugars. it can. Further, when it is desired to collect a nucleic acid having a specific sequence, the needle may be modified with a nucleic acid having a sequence complementary to the nucleic acid.
【0014】針の修飾方法は、修飾する物質及び針の種
類に応じて適宜決めることができる。例えば、オリゴdT
でZnOウィスカーを修飾する場合は、表面にアミノ基を
導入したウィスカーとオリゴdTを含み5'チオール化した
オリゴDNAとを、適当な架橋剤と反応させることにより
行うことができる。The method of modifying the needle can be appropriately determined depending on the substance to be modified and the type of needle. For example, oligo dT
When the ZnO whiskers are modified with, the reaction can be performed by reacting the amino group-introduced whiskers with the oligo dT-containing 5'-thiolated oligo DNA with an appropriate cross-linking agent.
【0015】微細な位置制御が可能な装置は、生細胞を
殺すことなく、針の刺し込み操作及び後述する引き抜き
操作が可能なものであればどのようなものでもよく、市
販のマイクロマニピュレーターや原子間力顕微鏡を使用
することができる。The device capable of finely controlling the position may be any device capable of piercing the needle and pulling out the needle as will be described later without killing living cells. A commercially available micromanipulator or atom A force microscope can be used.
【0016】針の生細胞への刺し込みは、例えば、原子
間力顕微鏡のカンチレバーに針を固定し、カンチレバー
を採取しようとする生細胞の上方に移動させた後、下方
に移動させることにより行うことができる。針のカンチ
レバーへの固定は一般的な方法、例えば、エポキシなど
を用いて行うことができる。このような針の刺し込み等
の操作は顕微鏡観察下で行うのが好ましい。The insertion of a needle into a living cell is carried out, for example, by fixing the needle to a cantilever of an atomic force microscope, moving the cantilever above the living cell to be collected, and then moving it downward. be able to. The needle can be fixed to the cantilever using a general method, for example, epoxy. It is preferable to perform such operations such as inserting the needle under a microscope.
【0017】採取源とする生細胞はどのようなものでも
よく、例えば、線維芽細胞、神経細胞、グリア細胞など
を例示できるが、これらに限定されるわけではない。Any living cells may be used as a collection source, and examples thereof include, but are not limited to, fibroblasts, nerve cells, and glial cells.
【0018】工程(2)では、前記針を、前記装置を用
いて、生細胞から引き抜く。In step (2), the needle is pulled out from the living cells by using the device.
【0019】針の刺し込みから引き抜きまでの時間は特
に限定されないが、細胞へのダメージを考えれば短い方
がよく、より多くの生体分子を取り出すには長い方がよ
い。刺し込みから引き抜きまでは、通常5〜10秒程度で
ある。The time from the insertion of the needle to the withdrawal is not particularly limited, but it is preferably short considering the damage to cells, and long is preferable for taking out more biomolecules. It usually takes about 5 to 10 seconds from insertion to removal.
【0020】以上の生体分子の採取方法を利用して、生
細胞内で発現している遺伝子の同定を行うことができ
る。即ち、生細胞内からmRANを採取し、そのmRNAがどの
遺伝子に由来するかを調べることにより、生細胞内でど
のような遺伝子が発現していたかがわかる。具体的な方
法としては、以下の第一の方法、及び第二の方法を例示
できる。By utilizing the above method of collecting biomolecules, the gene expressed in living cells can be identified. That is, it is possible to know what kind of gene was expressed in living cells by collecting mRAN from living cells and examining which gene the mRNA originated from. Specific methods include the following first method and second method.
【0021】第一の方法は、少なくとも以下の(1)及
び(2)の工程を含むことを特徴とするものである。
(1)上記方法によって生細胞からmRNAを採取する工程
(2)前記mRNAと、発現が予想される遺伝子に特異的な
配列を含むオリゴヌクレオチドとを共存させ、前者を鋳
型とし、後者をプライマーとするポリメラーゼ連鎖反応
が起きるかどうかを調べる工程
mRNAが、予想した遺伝子由来のものであればポリメラー
ゼ連鎖反応による増幅断片が生じるが、予想した遺伝子
由来のものでなければ増幅断片は生じない。従って、増
幅断片の有無を電気泳動等により調べることにより、生
細胞内で発現していた遺伝子がどのようなものであった
かがわかる。The first method is characterized by including at least the following steps (1) and (2). (1) Step of collecting mRNA from living cells by the above method (2) The mRNA and an oligonucleotide containing a sequence specific to a gene whose expression is expected to coexist, the former as a template, and the latter as a primer The step of examining whether or not the polymerase chain reaction occurs If the mRNA is derived from the expected gene, an amplified fragment by the polymerase chain reaction is produced, but if not from the expected gene, the amplified fragment is not produced. Therefore, by examining the presence or absence of the amplified fragment by electrophoresis or the like, it is possible to know what kind of gene was expressed in living cells.
【0022】第二の方法は、少なくとも以下の(1)〜
(3)の工程を含むことを特徴とするものである。
(1)上記方法によって生細胞からmRNAを採取する工程
(2)前記mRNAからcDNAを合成する工程
(3)前記cDNAを、発現が予想される複数の遺伝子断片
が固定されているDNAチップに近づけ、前記cDNAと固定
されている遺伝子断片間に生じる力を測定する工程
cDNAが予想した遺伝子断片に由来するものであれば、cD
NAを遺伝子断片に近づけると、両者間の引力、斥力に変
化が生じる。従って、この変化を調べることにより、生
細胞内で発現していた遺伝子がどのようなものであった
かがわかる。引力等の変化は、原子間力顕微鏡などによ
り測定することができる。The second method is at least the following (1) to
It is characterized by including the step (3). (1) Step of collecting mRNA from living cells by the above method (2) Step of synthesizing cDNA from said mRNA (3) Bringing said cDNA close to a DNA chip on which a plurality of gene fragments whose expression is expected are fixed The step of measuring the force generated between the cDNA and the fixed gene fragment, if the cDNA is derived from the expected gene fragment, cD
When NA is brought closer to a gene fragment, the attractive force and repulsive force between them change. Therefore, by examining this change, it is possible to know what kind of gene was expressed in living cells. The change in attractive force or the like can be measured by an atomic force microscope or the like.
【0023】[0023]
【実施例】1.ZnOウィスカーの修飾
ZnOウィスカーを無水トルエンで洗浄後、50%アミノプ
ロピルシランの入ったトルエン溶液中で一晩ローテータ
ーで攪拌し、ZnOウィスカー表面にアミノ基を導入し
た。反応終了後、ZnOをメタノールで3回洗浄し、その
後、メタノール中に保存した。次に、架橋剤(Sulfo-LC
-SPDP)を使って5'チオール化したオリゴDNA (AAACGACG
GCCAGTGAATTGTAATACGACTCACTATAGGCGC(T)24)をZnOウィ
スカー表面に化学的に結合させた。[Example] 1. Modification of ZnO Whiskers After washing the ZnO whiskers with anhydrous toluene, the mixture was stirred overnight in a toluene solution containing 50% aminopropylsilane with a rotator to introduce amino groups on the surface of the ZnO whiskers. After completion of the reaction, ZnO was washed with methanol three times and then stored in methanol. Next, cross-linking agent (Sulfo-LC
-SPDP) 5'-thiolated oligo DNA (AAACGACG
GCCAGTGAATTGTAATACGACTCACTATAGGCGC (T) 24 ) was chemically bound to the ZnO whisker surface.
【0024】修飾が上手くいったかどうかは、赤い蛍光
を発する色素を結合したポリAとの反応により調べた。
図1BにポリAとの反応により赤く染まったZnOウィスカ
ーを示す。
2.ZnOウィスカーのAFMカンチレバーへの固定
実体顕微鏡(SZX12、オリンパス)にヒーター(MP200DM
SH、Kitazato)及びマイクロマニピュレータ(成茂科
学)をセットした。ヒーターの温度は70℃に設定した。
小さく切ったスライドガラス(約1.5cm角程度)を3個用
意し、それぞれにエポキシ(グレード1001、油化シェ
ル。融点64℃)、ZnOウィスカー、AFMチップを載せた。Whether the modification was successful was examined by reaction with poly A having a red fluorescent dye attached thereto.
FIG. 1B shows ZnO whiskers dyed red by the reaction with poly A. 2. Fixed stereo microscope (SZX12, Olympus) on the AFM cantilever of ZnO whiskers and heater (MP200DM)
SH, Kitazato) and a micromanipulator (Narishige Kagaku) were set. The temperature of the heater was set to 70 ° C.
Three pieces of slide glass (about 1.5 cm square) cut into small pieces were prepared, and epoxy (grade 1001, oiled shell, melting point 64 ° C), ZnO whiskers, and AFM chip were placed on each.
【0025】エポキシが溶け、ZnOウィスカーが乾燥し
た時点で、以下の作業を開始した。実体顕微鏡で観察し
つつ、マニピュレータのマイクロピペットをエポキシに
少しだけ浸けた。これにより、ピペット先端にごく少量
のエポキシが、球状になって付着した。そのピペット先
端を、今度はAFMカンチレバー先端に軽く触れさせた。
これにより、カンチレバー先端にもごく少量のエポキシ
が付いた。次に、もうひとつのマニピュレータピペット
を使い、ZnOウィスカーをひとつだけ拾い上げた。ZnOウ
ィスカーに針先を触れさせると、静電気力によってZnO
ウィスカーがピペット先端に付着した。そして拾い上げ
たZnOウィスカーを、先ほどエポキシを付けた場所の上
に置き、室温に戻すと樹脂が固まって、ZnOウィスカー
がAFMカンチレバー先端に固定された。
3.試料とする生細胞の調製
本実施例では、RNAの採取源として、BALB/cマウス由来
の繊維芽細胞であるBALB 3T3細胞を用いた。培養環境
は、5% CO2存在下で、37℃に温度を保つようにした。
培地は、D-MEM/F-12培地(Gibco BRL)に100 U/mLペニ
シリン - 100 mg/mLストレプトマイシン(Gibco BRL )
を加えたものを作り、それと非働化処理したFBS(fetal
bovine serum、JRH Biosciences)血清の比率が9:1に
なるよう混合した培地を用いた。継代後、約3日後に培
地を交換した。継代は、約1週間毎に行った。継代方法
であるが、コンフルエントになった細胞を0.25%トリプ
シン - 1mM EDTA(Gibco BRL)で処理し、遠心沈殿(70
0 rpm、10分)させた後、全体の1/10を継代した。通常
は角ディッシュ(T-25)を用いて培養するが、本実施例
では35mmペトリディッシュを用いた。
4.生細胞からのmRNAの採取
原子間力顕微鏡の試料台に、上述のBALB 3T3細胞を置
き、カンチレバーに固定されたZnOウィスカーを細胞の
刺したい部位に移動させた。この作業は、原子間力顕微
鏡に付随する光学顕微鏡で観察しながら行った。ZnOウ
ィスカーの位置調整が完了した後、ピエゾを動かして、
ZnOウィスカーを細胞に刺した。ZnOウィスカーを細胞に
刺した直後の写真を図2に示す。図中の丸印で示された
細胞にZnOウィスカーを刺した。ZnOウィスカーは、この
図ではみえないが、カンチレバー(三角の部分)の先端
に付いている。When the epoxy melted and the ZnO whiskers dried, the following work was started. While observing with a stereomicroscope, the micropipette of the manipulator was slightly dipped in epoxy. This caused a very small amount of epoxy to become spherical and adhere to the pipette tip. The tip of the pipette was lightly touched with the tip of the AFM cantilever this time.
This left a very small amount of epoxy on the tip of the cantilever. Next, using another manipulator pipette, I picked up only one ZnO whisker. Touching the ZnO whiskers with the needle tip causes ZnO
Whiskers attached to the tip of the pipette. Then, the ZnO whiskers picked up were placed on the place where the epoxy was attached, and when the temperature was returned to room temperature, the resin solidified and the ZnO whiskers were fixed to the tip of the AFM cantilever. 3. Preparation of Live Cells as Samples In this example, BALB 3T3 cells, which are BALB / c mouse-derived fibroblasts, were used as the RNA collection source. The culture environment was kept at 37 ° C. in the presence of 5% CO 2 .
The medium is 100 U / mL penicillin-100 mg / mL streptomycin (Gibco BRL) in D-MEM / F-12 medium (Gibco BRL).
FBS (fetal (fetal)
Bovine serum, JRH Biosciences) A mixed medium was used so that the ratio of serum was 9: 1. The medium was exchanged about 3 days after the passage. Passaging was performed about every week. As a subculture method, confluent cells were treated with 0.25% trypsin-1 mM EDTA (Gibco BRL) and spun down (70
(0 rpm, 10 minutes), and then passaged 1/10 of the whole. Usually, a square dish (T-25) is used for culturing, but a 35 mm petri dish was used in this example. 4. Collection of mRNA from living cells The above-mentioned BALB 3T3 cells were placed on the sample stand of an atomic force microscope, and the ZnO whiskers fixed to the cantilever were moved to the site where the cells were to be stabbed. This work was performed while observing with an optical microscope attached to the atomic force microscope. After completing the ZnO whisker position adjustment, move the piezo,
Cells were stabbed with ZnO whiskers. A photograph immediately after the cells were stabbed with ZnO whiskers is shown in FIG. The cells indicated by circles in the figure were stabbed with ZnO whiskers. The ZnO whiskers, which are not visible in this figure, are attached to the tip of the cantilever (triangle part).
【0026】ZnOウィスカーを細胞に刺した後、すばや
くカンチレバーを原子間力顕微鏡から取り外した。
5.mRNAの解析
ZnOウィスカーに付着したmRNAを鋳型とし、QIAGENのPCR
用キットを用いて、RT-PCRとnested PCRを行った。プラ
イマーは、β-アクチン遺伝子に特異的な二組のプライ
マーを用いた。これらのプライマーを用いた場合、ZnO
ウィスカーにβ-アクチン遺伝子由来のmRNAが付着して
いれば、約400bpの断片が増幅される(図3)。After puncturing the cells with ZnO whiskers, the cantilevers were quickly removed from the atomic force microscope. 5. mRNA analysis QIAGEN PCR using mRNA attached to ZnO whiskers as a template
RT-PCR and nested PCR were performed using the kit. As the primers, two sets of primers specific to the β-actin gene were used. With these primers, ZnO
If β-actin gene-derived mRNA is attached to the whiskers, a fragment of about 400 bp is amplified (Fig. 3).
【0027】PCRの条件及びプライマーの配列は下記の
通りである。
<1st RT-PCRのプライマー>
Foward Primer :5'-GTG GGC CGC TCT AGG CAC CAA-3'
(配列番号1)
Reverse Primer:5'-CTC TTT GAT GTC ACG CAC GAT TTC-
3'(配列番号2)
<2nd nested PCRのプライマー>
Foward Primer :5'-GAC TCC TAT GTG GGT GAC GAG G-3'
(配列番号3)
Reverse Primer:5'-GGA TCT TCA TGA GGT AGT CCG TCA-
3'(配列番号4)
上記二段階のPCRを行った後、その増幅産物を電気泳動
した。ゲルの写真を図4に示す。この図に示すように、
中央のレーンには約400bpのバンドが検出された。この
バンドは、β-アクチンmRNA由来のものであると考えら
れる。なお、図中の左端のレーンはマーカー、右端のレ
ーンはコントロールのレーンである。The PCR conditions and primer sequences are as follows. <Primer of 1 st RT-PCR> Foward Primer : 5'-GTG GGC CGC TCT AGG CAC CAA-3 '
(SEQ ID NO: 1) Reverse Primer: 5'-CTC TTT GAT GTC ACG CAC GAT TTC-
3 '(SEQ ID NO: 2) <2 nd nested PCR primers> Foward Primer: 5'-GAC TCC TAT GTG GGT GAC GAG G-3'
(SEQ ID NO: 3) Reverse Primer: 5'-GGA TCT TCA TGA GGT AGT CCG TCA-
3 '(SEQ ID NO: 4) After performing the above two-step PCR, the amplification product was electrophoresed. A photograph of the gel is shown in FIG. As shown in this figure,
A band of about 400 bp was detected in the center lane. This band is considered to be derived from β-actin mRNA. The leftmost lane in the figure is a marker and the rightmost lane is a control lane.
【0028】[0028]
【発明の効果】本発明は、生きている状態の細胞から生
体分子を採取する方法を提供する。ある細胞における遺
伝子発現の経時的変化を調べる場合、従来はクローン化
された複数の細胞を用いていたが、本発明の方法によ
り、一個の細胞についての経時的変化を調べることが可
能になる。これにより、クローン細胞を用いる場合より
も、より正確な発現情報を得ることができるようにな
る。また、クローン化できない細胞についても、発現す
る遺伝子の経時的変化を調べることが可能になる。INDUSTRIAL APPLICABILITY The present invention provides a method for collecting biomolecules from living cells. In the case of examining the time course of gene expression in a certain cell, conventionally, a plurality of cloned cells were used, but the method of the present invention makes it possible to examine the time course of one cell. This makes it possible to obtain more accurate expression information than when using clonal cells. In addition, it becomes possible to investigate the time-dependent changes in the expressed gene even in cells that cannot be cloned.
【0029】更に、本発明の方法では、ウィスカーの刺
す場所を変えることにより、細胞の場所による発現の違
いも調べることができる。Further, in the method of the present invention, by changing the place where the whisker is stabbed, the difference in expression depending on the place of the cell can be examined.
【0030】[0030]
【配列表】 SEQUENCE LISTING <110> President of Tokyo Institute of Technology <120> METHOD FOR PICKING BIOMOLECULES FROM A VIABLE CELL <130> P01-054 <160> 4 <170> PatentIn Ver. 2.1 <210> 1 <211> 21 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: SYNTHETIC DNA <400> 1 gtgggccgct ctaggcacca a 21 <210> 2 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: SYNTHETIC DNA <400> 2 ctctttgatg tcacgcacga tttc 24 <210> 3 <211> 22 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: SYNTHETIC DNA <400> 3 gactcctatg tgggtgacga gg 22 <210> 4 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: SYNTHETIC DNA <400> 4 ggatcttcat gaggtagtcc gtca 24[Sequence list] SEQUENCE LISTING <110> President of Tokyo Institute of Technology <120> METHOD FOR PICKING BIOMOLECULES FROM A VIABLE CELL <130> P01-054 <160> 4 <170> PatentIn Ver. 2.1 <210> 1 <211> 21 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: SYNTHETIC DNA <400> 1 gtgggccgct ctaggcacca a 21 <210> 2 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: SYNTHETIC DNA <400> 2 ctctttgatg tcacgcacga tttc 24 <210> 3 <211> 22 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: SYNTHETIC DNA <400> 3 gactcctatg tgggtgacga gg 22 <210> 4 <211> 24 <212> DNA <213> Artificial Sequence <220> <223> Description of Artificial Sequence: SYNTHETIC DNA <400> 4 ggatcttcat gaggtagtcc gtca 24
【配列番号1】配列番号1は、実施例で行ったRT-PCRの
Foward Primerの塩基配列を示す。[SEQ ID NO: 1] SEQ ID NO: 1 is of RT-PCR performed in the examples.
The nucleotide sequence of the Foward Primer is shown.
【0031】[0031]
【配列番号2】配列番号2は、実施例で行ったRT-PCRの
Reverse Primerの塩基配列を示す。[SEQ ID NO: 2] SEQ ID NO: 2 is the RT-PCR sequence of the example.
The base sequence of Reverse Primer is shown.
【0032】[0032]
【配列番号3】配列番号3は、実施例で行ったnested P
CRのFoward Primerの塩基配列を示す。[SEQ ID NO: 3] SEQ ID NO: 3 is the nested P sequence in the example.
The forward sequence of the CR forward primer is shown.
【0033】[0033]
【配列番号4】配列番号4は、実施例で行ったnested P
CRのReverse Primerの塩基配列を示す。[SEQ ID NO: 4] SEQ ID NO: 4 is the nested P sequence in the example.
The nucleotide sequence of the Reverse Primer of CR is shown.
【図1】ZnOウィスカーの形状を示す顕微鏡写真(図1
A)、オリゴdTで修飾したZnOウィスカーと蛍光性ポリA
のアニーリングの様子を示す蛍光顕微鏡写真(図1B)FIG. 1 is a micrograph showing the shape of ZnO whiskers (FIG. 1
A), ZnO whiskers modified with oligo dT and fluorescent poly A
Fluorescence micrograph showing the annealing process (Fig. 1B)
【図2】ZnOウィスカーを細胞に刺した直後の写真[Figure 2] Photo taken immediately after ZnO whiskers were stabbed into cells
【図3】実施例で使用したPCRプライマーと鋳型となるm
RNAの位置を示す図[FIG. 3] PCR primers used in Examples and m used as a template
Diagram showing the position of RNA
【図4】細胞から回収したmRNAを鋳型としたPCRによる
増幅断片を示す写真FIG. 4 is a photograph showing a fragment amplified by PCR using mRNA recovered from cells as a template.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 金 賢徹 東京都目黒区大岡山2丁目12番1号 東京 工業大学内 Fターム(参考) 4B024 AA20 CA04 CA09 CA12 DA02 GA11 HA14 4B063 QA01 QA13 QQ53 QR32 QR55 QR62 QS12 QS25 QS34 ─────────────────────────────────────────────────── ─── Continued front page (72) Inventor Kim, Toru 2-12-1 Ookayama, Meguro-ku, Tokyo Tokyo Inside the university F-term (reference) 4B024 AA20 CA04 CA09 CA12 DA02 GA11 HA14 4B063 QA01 QA13 QQ53 QR32 QR55 QR62 QS12 QS25 QS34
Claims (7)
程を含むことを特徴とする生体分子の採取方法。 (1)採取しようとする生体分子と結合し得る針を、微
細な位置制御が可能な装置を用いて、生細胞に刺し込む
工程 (2)前記針を、前記装置を用いて、生細胞から引き抜
く工程1. A method for collecting biomolecules, which comprises at least the following steps (1) and (2): (1) A step of inserting a needle capable of binding to a biomolecule to be collected into a living cell by using a device capable of finely controlling the position (2) A step of inserting the needle from the living cell by using the device Extraction process
力顕微鏡であることを特徴とする請求項1記載の生体分
子の採取方法。2. The method for collecting biomolecules according to claim 1, wherein the device capable of fine position control is an atomic force microscope.
質で修飾されたウィスカーであることを特徴とする請求
項1又は2記載の生体分子の採取方法。3. The method for collecting a biomolecule according to claim 1, wherein the needle is a whisker modified with a substance capable of specifically binding to the biomolecule.
とを特徴とする請求項3記載の生体分子の採取方法。4. The method for collecting biomolecules according to claim 3, wherein the whiskers are ZnO whiskers.
のいずれか一項に記載の生体分子の採取方法。5. The biological molecule is mRNA, according to any one of claims 1 to 4.
The method for collecting a biomolecule according to any one of 1.
程を含むことを特徴とする生細胞内で発現している遺伝
子の同定方法。 (1)請求項5記載の方法によって生細胞からmRNAを採
取する工程 (2)前記mRNAと、発現が予想される遺伝子に特異的な
配列を含むオリゴヌクレオチドとを共存させ、前者を鋳
型とし、後者をプライマーとするポリメラーゼ連鎖反応
が起きるかどうかを調べる工程6. A method for identifying a gene expressed in a living cell, which comprises at least the following steps (1) and (2): (1) A step of collecting mRNA from a living cell by the method according to claim 5, (2) the mRNA and an oligonucleotide containing a sequence specific to a gene whose expression is expected to coexist, and the former is used as a template, Step of investigating whether the polymerase chain reaction using the latter as a primer occurs
を含むことを特徴とする生細胞内で発現している遺伝子
の同定方法。 (1)請求項5記載の方法によって生細胞からmRNAを採
取する工程 (2)前記mRNAからcDNAを合成する工程 (3)前記cDNAを、発現が予想される複数の遺伝子断片
が固定されているDNAチップに近づけ、前記cDNAと固定
されている遺伝子断片間に生じる力を測定する工程7. A method for identifying a gene expressed in a living cell, which comprises at least the following steps (1) to (3): (1) A step of collecting mRNA from living cells by the method according to claim 5 (2) A step of synthesizing cDNA from the mRNA (3) A plurality of gene fragments whose expression is expected to be fixed in the cDNA Step of measuring the force generated between the cDNA and the fixed gene fragment by bringing it close to the DNA chip
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001284298A JP3837480B2 (en) | 2001-09-19 | 2001-09-19 | How to collect biomolecules from living cells |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001284298A JP3837480B2 (en) | 2001-09-19 | 2001-09-19 | How to collect biomolecules from living cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003088383A true JP2003088383A (en) | 2003-03-25 |
| JP3837480B2 JP3837480B2 (en) | 2006-10-25 |
Family
ID=19107647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001284298A Expired - Lifetime JP3837480B2 (en) | 2001-09-19 | 2001-09-19 | How to collect biomolecules from living cells |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3837480B2 (en) |
Cited By (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004092369A1 (en) * | 2003-04-11 | 2004-10-28 | Riken | Method of microinjection and device therefor |
| JP2006006223A (en) * | 2004-06-25 | 2006-01-12 | Canon Inc | Apparatus for introducing and collecting microparticles into cells, and method for introducing and collecting cells or target biomolecules in cells |
| JP2006246731A (en) * | 2005-03-09 | 2006-09-21 | National Institute Of Advanced Industrial & Technology | Detection method of live cell protein by immunodynamic measurement |
| WO2009009610A3 (en) * | 2007-07-09 | 2009-03-12 | Univ Brigham Young | Methods and devices for charged molecule manipulation |
| JP2011523064A (en) * | 2008-06-06 | 2011-08-04 | ユニバーシティー・オブ・ワシントン | Method and system for concentrating particles from solution |
| US8247971B1 (en) | 2009-03-19 | 2012-08-21 | Moxtek, Inc. | Resistively heated small planar filament |
| US8498381B2 (en) | 2010-10-07 | 2013-07-30 | Moxtek, Inc. | Polymer layer on X-ray window |
| US8736138B2 (en) | 2007-09-28 | 2014-05-27 | Brigham Young University | Carbon nanotube MEMS assembly |
| US8750458B1 (en) | 2011-02-17 | 2014-06-10 | Moxtek, Inc. | Cold electron number amplifier |
| US8761344B2 (en) | 2011-12-29 | 2014-06-24 | Moxtek, Inc. | Small x-ray tube with electron beam control optics |
| US8804910B1 (en) | 2011-01-24 | 2014-08-12 | Moxtek, Inc. | Reduced power consumption X-ray source |
| US8929515B2 (en) | 2011-02-23 | 2015-01-06 | Moxtek, Inc. | Multiple-size support for X-ray window |
| US8940092B1 (en) | 2008-10-27 | 2015-01-27 | University Of Washington Through Its Center For Commercialization | Hybrid fibers, devices using hybrid fibers, and methods for making hybrid fibers |
| US8948345B2 (en) | 2010-09-24 | 2015-02-03 | Moxtek, Inc. | X-ray tube high voltage sensing resistor |
| US8989354B2 (en) | 2011-05-16 | 2015-03-24 | Brigham Young University | Carbon composite support structure |
| US9076628B2 (en) | 2011-05-16 | 2015-07-07 | Brigham Young University | Variable radius taper x-ray window support structure |
| US9174412B2 (en) | 2011-05-16 | 2015-11-03 | Brigham Young University | High strength carbon fiber composite wafers for microfabrication |
| US9173623B2 (en) | 2013-04-19 | 2015-11-03 | Samuel Soonho Lee | X-ray tube and receiver inside mouth |
| US9305735B2 (en) | 2007-09-28 | 2016-04-05 | Brigham Young University | Reinforced polymer x-ray window |
| WO2023002890A1 (en) * | 2021-07-20 | 2023-01-26 | 東洋製罐グループホールディングス株式会社 | Means for controlling intracellular reaction utilizing needle-shaped body |
| JP2023015592A (en) * | 2021-07-20 | 2023-02-01 | 東洋製罐グループホールディングス株式会社 | Means for controlling intracellular reaction utilizing needle-shaped body |
| JP2023015590A (en) * | 2021-07-20 | 2023-02-01 | 東洋製罐グループホールディングス株式会社 | Means for controlling intracellular reaction utilizing needle-shaped particle |
| JP2023055320A (en) * | 2021-10-06 | 2023-04-18 | 東洋製罐グループホールディングス株式会社 | Means for controlling intracellular reactions using needle-shaped bodies by using hypotonic liquid in combination |
-
2001
- 2001-09-19 JP JP2001284298A patent/JP3837480B2/en not_active Expired - Lifetime
Cited By (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8304240B2 (en) | 2003-04-11 | 2012-11-06 | Olympus Corporation | Microinjection method and device |
| JPWO2004092369A1 (en) * | 2003-04-11 | 2006-07-06 | 独立行政法人理化学研究所 | Microinjection method and apparatus |
| JP4530991B2 (en) * | 2003-04-11 | 2010-08-25 | 独立行政法人理化学研究所 | Microinjection method and apparatus |
| WO2004092369A1 (en) * | 2003-04-11 | 2004-10-28 | Riken | Method of microinjection and device therefor |
| JP2006006223A (en) * | 2004-06-25 | 2006-01-12 | Canon Inc | Apparatus for introducing and collecting microparticles into cells, and method for introducing and collecting cells or target biomolecules in cells |
| JP2006246731A (en) * | 2005-03-09 | 2006-09-21 | National Institute Of Advanced Industrial & Technology | Detection method of live cell protein by immunodynamic measurement |
| WO2009009610A3 (en) * | 2007-07-09 | 2009-03-12 | Univ Brigham Young | Methods and devices for charged molecule manipulation |
| US10119151B2 (en) | 2007-07-09 | 2018-11-06 | Brigham Young University | Methods and devices for charged molecule manipulation |
| US9305735B2 (en) | 2007-09-28 | 2016-04-05 | Brigham Young University | Reinforced polymer x-ray window |
| US8736138B2 (en) | 2007-09-28 | 2014-05-27 | Brigham Young University | Carbon nanotube MEMS assembly |
| US9097664B2 (en) | 2008-06-06 | 2015-08-04 | University Of Washington | Method and system for concentrating particles from a solution |
| US8632669B2 (en) | 2008-06-06 | 2014-01-21 | University Of Washington | Method and system for concentrating particles from a solution |
| JP2011523064A (en) * | 2008-06-06 | 2011-08-04 | ユニバーシティー・オブ・ワシントン | Method and system for concentrating particles from solution |
| US9518956B2 (en) | 2008-06-06 | 2016-12-13 | University Of Washington | Particle concentration system |
| US8940092B1 (en) | 2008-10-27 | 2015-01-27 | University Of Washington Through Its Center For Commercialization | Hybrid fibers, devices using hybrid fibers, and methods for making hybrid fibers |
| US8247971B1 (en) | 2009-03-19 | 2012-08-21 | Moxtek, Inc. | Resistively heated small planar filament |
| US8948345B2 (en) | 2010-09-24 | 2015-02-03 | Moxtek, Inc. | X-ray tube high voltage sensing resistor |
| US8498381B2 (en) | 2010-10-07 | 2013-07-30 | Moxtek, Inc. | Polymer layer on X-ray window |
| US8964943B2 (en) | 2010-10-07 | 2015-02-24 | Moxtek, Inc. | Polymer layer on X-ray window |
| US8804910B1 (en) | 2011-01-24 | 2014-08-12 | Moxtek, Inc. | Reduced power consumption X-ray source |
| US8750458B1 (en) | 2011-02-17 | 2014-06-10 | Moxtek, Inc. | Cold electron number amplifier |
| US8929515B2 (en) | 2011-02-23 | 2015-01-06 | Moxtek, Inc. | Multiple-size support for X-ray window |
| US9174412B2 (en) | 2011-05-16 | 2015-11-03 | Brigham Young University | High strength carbon fiber composite wafers for microfabrication |
| US9076628B2 (en) | 2011-05-16 | 2015-07-07 | Brigham Young University | Variable radius taper x-ray window support structure |
| US8989354B2 (en) | 2011-05-16 | 2015-03-24 | Brigham Young University | Carbon composite support structure |
| US8761344B2 (en) | 2011-12-29 | 2014-06-24 | Moxtek, Inc. | Small x-ray tube with electron beam control optics |
| US9173623B2 (en) | 2013-04-19 | 2015-11-03 | Samuel Soonho Lee | X-ray tube and receiver inside mouth |
| WO2023002890A1 (en) * | 2021-07-20 | 2023-01-26 | 東洋製罐グループホールディングス株式会社 | Means for controlling intracellular reaction utilizing needle-shaped body |
| JP2023015592A (en) * | 2021-07-20 | 2023-02-01 | 東洋製罐グループホールディングス株式会社 | Means for controlling intracellular reaction utilizing needle-shaped body |
| JP2023015590A (en) * | 2021-07-20 | 2023-02-01 | 東洋製罐グループホールディングス株式会社 | Means for controlling intracellular reaction utilizing needle-shaped particle |
| JP7767756B2 (en) | 2021-07-20 | 2025-11-12 | 東洋製罐グループホールディングス株式会社 | A means of controlling intracellular reactions using needle-shaped structures |
| JP7767755B2 (en) | 2021-07-20 | 2025-11-12 | 東洋製罐グループホールディングス株式会社 | A method for controlling intracellular reactions using needle-shaped particles |
| JP2023055320A (en) * | 2021-10-06 | 2023-04-18 | 東洋製罐グループホールディングス株式会社 | Means for controlling intracellular reactions using needle-shaped bodies by using hypotonic liquid in combination |
| JP7786112B2 (en) | 2021-10-06 | 2025-12-16 | 東洋製罐グループホールディングス株式会社 | A method for controlling intracellular reactions using needle-shaped structures in combination with hypotonic solutions |
Also Published As
| Publication number | Publication date |
|---|---|
| JP3837480B2 (en) | 2006-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3837480B2 (en) | How to collect biomolecules from living cells | |
| US12195790B2 (en) | Methods for improved in situ detection of nucleic acids and spatial analysis | |
| US20240417784A1 (en) | Methods, compositions, kits, and systems for enhancing analyte capture for spatial analysis | |
| US20230295722A1 (en) | Methods for printing cells and generating arrays of barcoded cells | |
| US20230332247A1 (en) | Methods, compositions, and systems for capturing analytes from glioblastoma samples | |
| US20250163501A1 (en) | Methods, kits, compositions, and systems for spatial analysis | |
| US20240218427A1 (en) | Methods, compositions, and systems for enhancing spatial analysis of analytes in a biological sample | |
| US20250313883A1 (en) | On-slide staining by primer extension | |
| US12031177B1 (en) | Methods of enhancing spatial resolution of transcripts | |
| WO2024145441A1 (en) | Methods, compositions, and kits for determining a location of a target nucleic acid in a fixed biological sample | |
| EP4484571A2 (en) | Methods and compositions for integrated in situ spatial assay | |
| EP4058598A1 (en) | Generating capture probes for spatial analysis | |
| CN108779488A (en) | The multiple unimolecule RNA visualizations of system are connected using double probe propinquities | |
| JP2021512631A (en) | Biomolecular probes for detecting gene and protein expression and methods for detecting them | |
| CN118451201A (en) | Space group learning platform and system | |
| CN101610847A (en) | Sample analyser | |
| WO2025072119A1 (en) | Methods, compositions, and kits for detecting spatial chromosomal interactions | |
| CN105358712A (en) | Analyte enrichment methods and compositions | |
| EP4162069A1 (en) | Method of single-cell analysis of multiple samples | |
| KR20210039289A (en) | Methods and apparatus for extracting nucleic acids maintaining two-dimensional spatial information from samples containing nucleic acids, and method and kit for spatial sequencing analysis using the same | |
| JPWO2016038929A1 (en) | Method for detecting the presence or absence of aneuploidy in fetal chromosomes | |
| EP4403647B1 (en) | Detection of proximity assay products in situ | |
| US20250369037A1 (en) | Methods, compositions, and kits for spatial detection of target nucleic acids | |
| HK40057000A (en) | On-slide staining by primer extension | |
| WO2026024934A1 (en) | Methods, compositions, and kits for spatial analysis by tagmentation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20010919 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20010919 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20040521 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20040623 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20040623 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050221 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050415 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050620 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20050708 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060117 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060206 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20060322 |
|
| R155 | Notification before disposition of declining of application |
Free format text: JAPANESE INTERMEDIATE CODE: R155 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 3837480 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| EXPY | Cancellation because of completion of term |